Detalhe da pesquisa
1.
One-Year Outcomes of the Paclitaxel-Eluting, Self-Expanding Stentys Stent System in the Treatment of Infrapopliteal Lesions in Patients With Critical Limb Ischemia.
J Endovasc Ther
; 24(3): 311-316, 2017 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-28351310
2.
Superiority of stent-grafts for in-stent restenosis in the superficial femoral artery: twelve-month results from a multicenter randomized trial.
J Endovasc Ther
; 22(1): 1-10, 2015 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-25775672
3.
4-French-compatible endovascular material is safe and effective in the treatment of femoropopliteal occlusive disease: results of the 4-EVER trial.
J Endovasc Ther
; 20(6): 746-56, 2013 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-24325689
4.
Head-to-Head Comparison of 2 Paclitaxel-Coated Balloons for Femoropopliteal Lesions.
JACC Cardiovasc Interv
; 16(23): 2900-2914, 2023 Dec 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-38092496
5.
Results of the Protégé EverFlex 200-mm-long nitinol stent (ev3) in TASC C and D femoropopliteal lesions.
J Vasc Surg
; 54(4): 1042-50, 2011 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-21636239
6.
EVOLUTION Study: 12-month results.
J Cardiovasc Surg (Torino)
; 60(4): 490-495, 2019 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-30698370
7.
Drug-eluting stents in superficial femoral artery treatment: could they be the standard of care?
J Cardiovasc Surg (Torino)
; 57(6): 806-810, 2016 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-27647337